Mordechai Liscovitch

Weizmann Institute of Science, Rehovot, Israel 
Cell Biology, Molecular Biology, Oncology
"Mordechai Liscovitch"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Erster O, Seger R, Liscovitch M. (2010) Ligand interaction scan (LIScan) in the study of ERK8. Biochemical and Biophysical Research Communications. 399: 37-41
Shatz M, Lustig G, Reich R, et al. (2010) Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Experimental Cell Research. 316: 1748-62
Ravid D, Chuderland D, Landsman L, et al. (2008) Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Experimental Cell Research. 314: 2762-73
Tencer L, Burgermeister E, Ebert MP, et al. (2008) Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Anticancer Research. 28: 895-906
Burgermeister E, Liscovitch M, Röcken C, et al. (2008) Caveats of caveolin-1 in cancer progression. Cancer Letters. 268: 187-201
Shatz M, Liscovitch M. (2008) Caveolin-1: a tumor-promoting role in human cancer. International Journal of Radiation Biology. 84: 177-89
Burgermeister E, Xing X, Röcken C, et al. (2007) Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Research. 67: 8519-26
Erster O, Eisenstein M, Liscovitch M. (2007) Ligand interaction scan: a general method for engineering ligand-sensitive protein alleles. Nature Methods. 4: 393-5
Burgermeister E, Chuderland D, Hanoch T, et al. (2007) Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Molecular and Cellular Biology. 27: 803-17
Liscovitch M, Ravid D. (2007) A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Letters. 245: 350-2
See more...